What does CUSIP 87650L103 represent in this 13F holders report?

CUSIP 87650L103 is the security identifier for TARS - Tarsus Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in Q1 2022?

50 institutional investors reported TARS - Tarsus Pharmaceuticals, Inc. - Common Stock for Q1 2022. Use the holders table for investor-level position and value details.

Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)

CUSIP: 87650L103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock
Shares outstanding: 42,450,857
Total 13F shares: 13,210,299
Share change: -1,281,157
Total reported value: $222,212,113
Price per share: $16.82
Number of holders: 50
Value change: -$29,618,514
Number of buys: 17
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 87650L103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Vivo Capital, LLC	13F	Company	7%	2,987,331	$67,215,000	—	31 Dec 2021	13F
RTW INVESTMENTS, LP	13F 3/4/5	Company · 10%+ Owner	4.7%	2,013,601	$45,306,000	—	31 Dec 2021	13F 3/4/5
FRAZIER MANAGEMENT LLC	13F	Company	3.3%	1,417,157	$31,886,000	—	31 Dec 2021	13F
Cormorant Asset Management, LP	13F	Company	3.3%	1,403,331	$31,575,000	—	31 Dec 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	3.1%	1,296,416	$29,169,000	—	31 Dec 2021	13F
TimesSquare Capital Management, LLC	13F	Company	1.6%	660,800	$14,868,000	—	31 Dec 2021	13F
COWEN AND COMPANY, LLC	13F	Company	1.2%	514,289	$11,572,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	1.1%	459,190	$10,332,000	—	31 Dec 2021	13F
BlackRock Finance, Inc.	13F	Company	1.1%	448,958	$10,101,000	—	31 Dec 2021	13F
Jefferies Group LLC	13F	Company	1%	422,993	$9,517,343	—	31 Dec 2021	13F
Sands Capital Alternatives, LLC	13F	Company	0.61%	260,000	$5,850,000	—	31 Dec 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.57%	242,451	$5,456,000	—	31 Dec 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.41%	174,736	$3,932,000	—	31 Dec 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.4%	170,000	$3,825,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	0.31%	129,742	$2,919,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	125,815	$2,830,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.17%	71,781	$1,615,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	47,181	$1,062,000	—	31 Dec 2021	13F
SG Americas Securities, LLC	13F	Company	0.1%	44,330	$997,000	—	31 Dec 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	28,103	$632,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.06%	25,286	$569,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.05%	21,763	$565,000	—	31 Dec 2021	13F
Invesco Ltd.	13F	Company	0.06%	23,904	$538,000	—	31 Dec 2021	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.03%	12,885	$289,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	0.03%	11,233	$253,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	10,662	$240,000	—	31 Dec 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.02%	8,990	$202,000	—	31 Dec 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	7,654	$172,000	—	31 Dec 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	5,872	$132,000	—	31 Dec 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	5,687	$128,000	—	31 Dec 2021	13F
Jason E. Tester	3/4/5	Director, 10%+ Owner	— class O/S missing	10,000	$109,900	—	15 Jun 2021	3/4/5
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	4,640	$104,000	—	31 Dec 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	4,480	$101,000	—	31 Dec 2021	13F
UBS Group AG	13F	Company	0.01%	3,084	$70,000	—	31 Dec 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	2,147	$49,000	—	31 Dec 2021	13F
CITIGROUP INC	13F	Company	0.01%	2,145	$48,000	—	31 Dec 2021	13F
STRS OHIO	13F	Company	0%	2,100	$47,000	—	31 Dec 2021	13F
Legal & General Group Plc	13F	Company	0%	818	$19,000	—	31 Dec 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	652	$14,000	—	31 Dec 2021	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	515	$12,000	—	31 Dec 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	200	$5,000	—	31 Dec 2021	13F
Spire Wealth Management	13F	Company	0%	100	$2,000	—	31 Dec 2021	13F
American Portfolios Advisors	13F	Company	0%	39	$878	—	31 Dec 2021	13F
TUCKER ASSET MANAGEMENT LLC	13F	Company	0%	4	$96	—	31 Dec 2021	13F

Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q1 2022

As of 31 Mar 2022, Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,210,299 shares. The largest 10 holders included Vivo Capital, LLC, RTW INVESTMENTS, LP, Frazier Life Sciences Management, L.P., Cormorant Asset Management, LP, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, BlackRock Inc., and Jefferies Group LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

Q1 2022 holders

Holder diff

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.